Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00817076Phase 3Completed
A Phase 3 trial of desloratadine in atopic dermatitis (AD), sponsored by Organon & Co.. Started Mar 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00817076.